How the Antivirals Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theAntivirals Market from 2025 to 2034?
The growing incidence of influenza is expected to drive further growth in the antiviral market. Influenza is a highly contagious respiratory illness that continues to affect millions worldwide each year. For example, the Centers for Disease Control and Prevention (CDC) reported that during the 2021-2022 flu season, there were 9 million flu illnesses and 100,000 hospitalizations. As such, the rising number of flu cases will contribute to increased demand for antiviral treatments.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp
#What is the Growth Potential of the Antivirals Market, and How Will It Perform by 2034?
The antivirals market has grown considerably in recent years. It is expected to expand from $106.13 billion in 2024 to $114.7 billion in 2025, with a CAGR of 8.1%. This expansion has been driven by the prevalence of viral infections, rising public health concerns, patent expirations, and supportive government measures.
The antivirals market is projected to experience significant growth, reaching $153.67 billion by 2029 at a CAGR of 7.6%. The expansion is driven by emerging viral threats and global health initiatives. Trends include technological advances, telemedicine, digital health, and personalized medicine.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437
How Are Market Trends and Innovations Revolutionizing theAntivirals Industry in Recent Times?
In the antiviral market, leading companies are creating more accessible and effective treatments like oral antivirals. These solutions enhance patient convenience and lower healthcare costs. For instance, in May 2023, Pfizer received FDA approval for Paxlovid, the first oral antiviral treatment for adults with mild-to-moderate COVID-19 who are at risk of developing severe symptoms.
Which Key Market Players Are Shaping the Future and Growth of theAntivirals Market?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
What Are the Core Segments of the Antivirals Market, and How Do They Contribute to Growth?
The antivirals market covered in this report is segmented –
1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications
Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp
What Regions Are Dominating the Antivirals Market Growth?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Antivirals Market 2025, By The Business Research Company:
Liposomal Drug Delivery Devices Global Market Report 2024
COVID-19 Drug Associated APIs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
Hospital Acquired Infections Testing Kits Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
